Amphastar Pharmaceuticals (AMPH) Income from Non-Controlling Interests (2018 - 2021)
Amphastar Pharmaceuticals (AMPH) posted quarterly Income from Non-Controlling Interests of $1.4 million for Q3 2021, up 61.56% year-over-year from $874000.0 in Q3 2020, and up 265.15% quarter-over-quarter from -$855000.0 in Q2 2021.
Amphastar Pharmaceuticals (AMPH) Income from Non-Controlling Interests (2018 - 2021) Analysis & Trends
Amphastar Pharmaceuticals' Income from Non-Controlling Interests history runs 4 years deep, the most recent figure standing at $1.4 million for Q3 2021.
- In Q3 2021, Income from Non-Controlling Interests rose 61.56% year-over-year to $1.4 million; the TTM figure through Dec 2021 stood at $1.6 million (down 45.66% YoY), while the FY2021 annual figure was $1.2 million, up 487.25% from the prior year.
- Income from Non-Controlling Interests for Q3 2021 stood at $1.4 million, up from -$855000.0 in the prior quarter.
- The five-year high for Income from Non-Controlling Interests was $6.6 million in Q4 2019, with the low at -$855000.0 in Q2 2021.
- The 4-year median for Income from Non-Controlling Interests is $867000.0 (2019), against an average of $1.1 million.
- The sharpest annual moves came in 2019 and 2021: Income from Non-Controlling Interests soared 4562.42% in 2019, then sank 169.12% in 2021.
- Amphastar Pharmaceuticals' Income from Non-Controlling Interests stood at -$149000.0 in 2018, then jumped by 4562.42% to $6.6 million in 2019, then tumbled by 92.77% to $481000.0 in 2020, then surged by 193.56% to $1.4 million in 2021.
- Business Quant data shows AMPH's Income from Non-Controlling Interests at $1.4 million in Q3 2021, -$855000.0 in Q2 2021, and $1.1 million in Q1 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.86 Bn | 42.90 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.19 Bn | 39.54 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.79 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.57 Bn | 22.77 Bn | 5.10 Bn | 376,434.15 |
| 5 | United Therapeutics | 22.15 Bn | 19.49 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.71 Bn | 11.18 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | - |
| 10 | Amphastar Pharmaceuticals | 944.46 Mn | 654.33 Mn | 93.47 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | -2.37 Mn |
| Sep 30, 2021 | 1.41 Mn |
| Jun 30, 2021 | -855,000.00 |
| Mar 31, 2021 | 1.08 Mn |
| Dec 31, 2020 | 481,000.00 |
| Sep 30, 2020 | 874,000.00 |
| Jun 30, 2020 | 1.24 Mn |
| Mar 31, 2020 | 424,000.00 |
| Dec 31, 2019 | 6.65 Mn |
| Sep 30, 2019 | 326,000.00 |
| Jun 30, 2019 | 867,000.00 |
| Mar 31, 2019 | 3.02 Mn |
| Dec 31, 2018 | -149,000.00 |
| Sep 30, 2018 | -773,000.00 |